Related Experiment Video
Updated: Mar 21, 2026
Fluorescence Molecular Tomography for In Vivo Imaging of Glioblastoma Xenografts
Published on: April 26, 2018
Emx2 as a novel tool to suppress glioblastoma
Carmen Falcone1, Antonio Daga2, Giampiero Leanza3
1Department of Neuroscience, SISSA, 34136 Trieste, Italy.
Abstract:
Glioblastoma is a devastating CNS tumour for which no cure is presently available. We wondered if manipulation of Emx2, which normally antagonizes cortico-cerebral astrogenesis by inhibiting proliferation of astrocyte progenitors, may be employed to counteract it. We found that Emx2 overexpression induced the collapse of seven out of seven in vitro tested glioblastoma cell lines. Moreover, it suppressed four out of four of these lines in vivo. As proven by dedicated rescue assays, the antioncogenic activity of Emx2 originated from its impact on at least six metabolic nodes, which accounts for the robustness of its effect. Finally, in two out of two tested lines, the tumor culture collapse was also achieved when Emx2 was driven by a neural stem cell-specific promoter, likely active within tumor-initiating cells. All that points to Emx2 as a novel, promising tool for therapy of glioblastoma and prevention of its recurrencies.
Insights
Emx2 overexpression effectively eliminated glioblastoma cells in vitro and in vivo. This novel therapeutic strategy targets metabolic pathways, offering a promising approach for glioblastoma treatment and recurrence prevention.
Area of Science:
- Neuro-oncology
- Molecular Biology
- Cancer Metabolism
Background:
- Glioblastoma is an aggressive brain tumor with limited treatment options.
- Emx2 is a gene known to inhibit astrocyte progenitor proliferation during development.
Purpose of the Study:
- To investigate the potential of Emx2 as a therapeutic agent against glioblastoma.
- To explore the mechanism by which Emx2 exerts its anti-tumor effects.
Main Methods:
- Overexpression of Emx2 in human glioblastoma cell lines.
- In vitro and in vivo efficacy studies of Emx2.
- Metabolic pathway analysis and rescue assays to determine Emx2's mechanism of action.
- Utilized neural stem cell-specific promoters to drive Emx2 expression.
Main Results:
- Emx2 overexpression led to the collapse of all seven tested glioblastoma cell lines in vitro.
- Emx2 suppressed tumor growth in vivo for all four tested glioblastoma cell lines.
- Emx2's anti-oncogenic activity is robust, stemming from its impact on at least six metabolic nodes.
- Emx2 expression driven by a neural stem cell-specific promoter also induced tumor collapse.
Conclusions:
- Emx2 demonstrates significant anti-glioblastoma activity, both in vitro and in vivo.
- The therapeutic effect of Emx2 is mediated through critical metabolic pathways.
- Emx2 represents a promising novel therapeutic tool for glioblastoma treatment and prevention of recurrence.
More Related Videos
12:52Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
Published on: November 28, 2015
09:40Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
